Research
Hormonal
Insulin resistance is a key pathophysiological factor in NAFLD, creating a bidirectional relationship where insulin resistance leads to liver fat accumulation and liver fat accumulation worsens insulin sensitivity.
Focus on improving insulin sensitivity. This involves managing weight, reducing refined carbs, and regular exercise. It helps both the liver and metabolic health.
StrongSupportsVERY_HIGH confidence
Insulin resistance has traditionally been identified as the key pathophysiological factor in NAFLD... NAFLD and metabolic syndrome are linked in a bidirectional way.
Why this rating
Well-established concept supported by multiple studies cited.
Source
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello et al. · International Journal of Molecular Sciences · 2019
DOI 10.3390/ijms20081948
narrative_reviewCited 190×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Nonalcoholic fatty liver disease (NAFLD) is strongly associated with metabolic syndrome, with prevalence rates of obesity (51%), type 2 diabetes (23%), and dyslipidemia (69%) significantly higher in NAFLD patients compared to the general population.Good
- Genetic variants, particularly PNPLA3 (rs738409 C>G), are strongly associated with liver steatosis and progression of liver damage, independent of insulin sensitivity and BMI.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →